• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Bill Collis Joins Random42 as Chairman

Share:

May 8, 2018

Highlights on this story:
  • Random42 Scientific Communication is a leading scientific communication studio specialising in medical animation and education, scientific virtual reality, interactive and visually engaging solutions.
  • Bill has served as CEO and President of The Foundry, where he led over a decade of change and innovation, transforming a niche London-based visual effects software company into a global, award-winning tech company.

Bill has a scientific background with a PhD in Signal Processing and extensive experience in various leadership roles, both executive and non-executive. He currently acts as both Chairman and Director for various other private equity backed companies. In addition to Random42, he is also Chairman of Disguise and sits on the boards of Cubic Motion and Exocad.

Previously, Bill has served as CEO and President of The Foundry, where he led over a decade of change and innovation, transforming a niche London-based visual effects software company into a global, award-winning tech company. He has vast experience in venture capital and private equity funding, intellectual property licensing, mergers and acquisitions and accessing international markets.

Random42 CEO and Medical Director, Ben Ramsbottom, commented on the appointment: “We are excited to bring Bill onboard, with his extensive knowledge of the animation industry, as well as his own experience building a market leading company that has gone through rapid growth he is the perfect fit to aid us on the next phase of Random42’s development.”

Bill’s leadership skills earned him an Ernst & Young Entrepreneur Of The Year award in 2012 and he is also the proud owner of numerous patents, a major feature movie credit, plus a prestigious Scientific and Technical Award from the Academy of Motion Picture Arts and Sciences for technology contributions to film.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

Bill commented: “I’m thrilled to be working with Ben and the rest of the Random42 team. Random42 are the clear market leaders in medical animation, VR and AR for the pharmaceutical industry and I’m looking forward to helping them continue their rapid growth over the coming years.”

About Random42

Random42 Scientific Communication is a leading scientific communication studio specialising in medical animation and education, scientific virtual reality, interactive and visually engaging solutions for global pharmaceutical and biotechnology companies. In their 26-year history they have produced core digital assets for over 650 product launches to date and won over 150 industry awards.

Date: May 08, 2018

Source: PRNewswire

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Less Than 10% of Suicide Prevention Apps Cover all the Recommended Strategies: NTU SingaporeLess Than 10% of Suicide Prevention Apps Cover all the Recommended Strategies: NTU Singapore
  • Horizon Therapeutics Plc Completes Acquisition of Viela Bio, Inc.Horizon Therapeutics Plc Completes Acquisition of Viela Bio, Inc.
  • Internet of Things, AI to Play Key Role in Future Smart HospitalsInternet of Things, AI to Play Key Role in Future Smart Hospitals
  • IBM Business Partner Evanston Technology Partners & Cylera Announce New Solution to Help Hospitals Manage & Protect Ventilators & Other Critical Medical Devices in the Age of COVID-19IBM Business Partner Evanston Technology Partners & Cylera Announce New Solution to Help Hospitals Manage & Protect Ventilators & Other Critical Medical Devices in the Age of COVID-19
  • Philips Launches Its First Clinical Product for Aiding Cognitive Assessment in the U.S.Philips Launches Its First Clinical Product for Aiding Cognitive Assessment in the U.S.
  • SAS & Duke Health Announce AI Partnership.SAS & Duke Health Announce AI Partnership.
  • 3 AI Trends for 2020: Moving Beyond Dazzle to High-Impact Collaboration3 AI Trends for 2020: Moving Beyond Dazzle to High-Impact Collaboration
  • AMAG to Acquire Ciraparantag Maker Perosphere PharmaceuticalsAMAG to Acquire Ciraparantag Maker Perosphere Pharmaceuticals

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications